Ramesh Kumar, President and CEO at Onconova Therapeutics, Inc. (ONTX), sold 60,000 shares at $15.05 ($903K) on 2014-01-30, disclosed to the SEC on 2014-02-03.
Scheduled sale ($903k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.05 | 20,000 | $301K | 33.3% |
| 2 | $15.03 | 20,000 | $301K | 33.3% |
| 3 | $15.07 | 20,000 | $301K | 33.4% |
| Total | $15.05 avg | 60,000 | $903K | 100% |
| Filing → |
| OCGN | SELL | 2022-04-20 | $21K | — | Filing → |
| OCGN | SELL | 2022-01-20 | $31K | — | Filing → |
| OCGN | SELL | 2021-10-20 | $122K | — | Filing → |